Vivani director gets 36,516 options at $1.22

Vivani Medical, Inc. director Aaron Mendelsohn received a grant of stock options as part of his non-employee director compensation.

Rhea-AI Filing Summary

Vivani Medical, Inc. director Aaron Mendelsohn received a grant of stock options as part of his non-employee director compensation. He was awarded a non-qualified option covering 36,516 shares of common stock at an exercise price of $1.22 per share, held directly.

The option vests in full on the earlier of the first anniversary of the grant or the next annual meeting of stockholders, contingent on continued board service through that date, and expires on June 23, 2036. This is a compensation-related award, not an open-market stock purchase or sale.

Insider Trade Summary

Grant/Award: 36,516 shares

Grant/Award 1 txn

Insider Mendelsohn Aaron

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Non-Qualified Stock Option (right to buy)	36,516	$1.22	$45K

Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 36,516 contracts (Direct)

Footnotes (2)

1. F1. Annual grant awarded pursuant to the Issuer's Non-Employee Director Compensation Policy.
2. F2. The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date.

Key Figures

Option grant size: 36,516 shares Exercise price: $1.22 per share Shares after transaction: 36,516 derivative shares +2 more

5 metrics

Option grant size 36,516 shares Non-qualified stock option awarded to director

Exercise price $1.22 per share Strike price for the stock option grant

Shares after transaction 36,516 derivative shares Total options held following the grant

Expiration date June 23, 2036 Option term end date

Vesting trigger Earlier of 1-year anniversary or next annual meeting Subject to continued board service

Key Terms

Non-Qualified Stock Option, Non-Employee Director Compensation Policy, vesting, annual meeting of stockholders

4 terms

Non-Qualified Stock Option financial

"Non-Qualified Stock Option (right to buy)"

A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.

Non-Employee Director Compensation Policy financial

"awarded pursuant to the Issuer's Non-Employee Director Compensation Policy"

vesting financial

"The option vests in total on the earlier of (i) the first anniversary"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

annual meeting of stockholders financial

"the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Vivani Medical (VANI) director Aaron Mendelsohn report on this Form 4?

Aaron Mendelsohn reported receiving a stock option grant. He was awarded a non-qualified option for 36,516 shares of Vivani Medical common stock at an exercise price of $1.22 per share as part of his non-employee director compensation.

How many Vivani Medical shares are covered by the new stock option grant?

The grant covers 36,516 shares of common stock. This non-qualified stock option gives Aaron Mendelsohn the right to buy up to 36,516 Vivani Medical shares at a fixed exercise price, subject to the vesting conditions described in the award.

What is the exercise price of Aaron Mendelsohn’s Vivani Medical stock options?

The exercise price is $1.22 per share. This means Mendelsohn can purchase up to 36,516 Vivani Medical common shares at $1.22 each once the option vests, regardless of the market price at that future time.

When do Aaron Mendelsohn’s Vivani Medical stock options vest?

The options vest in full on a future single date. Vesting occurs on the earlier of the first anniversary of the grant or the next annual meeting of stockholders, provided he continues to serve as a director through that date.

When do the Vivani Medical stock options granted to Aaron Mendelsohn expire?

The stock options expire on June 23, 2036. If the options are not exercised by that expiration date, the right to buy the 36,516 shares at $1.22 per share will lapse and become worthless.

Is Aaron Mendelsohn’s Vivani Medical Form 4 a stock purchase or a compensation grant?

This Form 4 reflects a compensation-related grant, not a purchase. The options were awarded under Vivani’s Non-Employee Director Compensation Policy, representing a grant of derivative securities rather than an open-market buy or sell transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/25/2026 - 07:38 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mendelsohn Aaron

(Last) (First) (Middle)

C/O VIVANI MEDICAL, INC.

1350 S. LOOP ROAD

(Street)

ALAMEDA CALIFORNIA 94502

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vivani Medical, Inc. [ VANI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$1.22	06/24/2026		A		36,516		(1)(2)	06/23/2036	Common Stock	36,516(2)	$1.22(2)	36,516(2)	D

Explanation of Responses:

1. Annual grant awarded pursuant to the Issuer's Non-Employee Director Compensation Policy.

2. The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date.

	/s/ Anthony Baldor, Attorney-in-fact	06/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)